SCHEMBL22428

SCHEMBL22428

COc1cc(C=O)ccc1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.64
TSHR P16473 1/20 0.64
FDPS P14324 1/20 0.55
TTR P02766 1/20 0.51
AOX1 Q06278 1/20 0.50
TRIM24 O15164 1/20 0.50
HPGD P15428 1/20 0.50
ALDH5A1 P51649 1/20 0.50
ABAT P80404 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
TRIM33 Q9UPN9 1/20 0.50
POLB P06746 1/20 0.49
MAPT P10636 5/20 0.48
KDM4E B2RXH2 1/20 0.48
DRD2 P14416 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
HTT P42858 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
LMNA P02545 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL498989 0.94 ALDH1A1 (0.64) ALDH1A1TSHRFDPSTTRAOX1
SCHEMBL30504088 0.94 ALDH1A1 (0.64) ALDH1A1TSHRFDPSTTRAOX1
SCHEMBL36740 0.92 ALDH1A1 (0.50) ALDH1A1TSHRFDPSTTRAOX1
SCHEMBL30360260 0.92 ALDH1A1 (0.50) ALDH1A1TSHRFDPSTTRAOX1
SCHEMBL6049278 0.85 XDH (0.55) ALDH1A1TSHRTTRHPGDMAPT
SCHEMBL6049277 0.85 XDH (0.55) ALDH1A1TSHRTTRHPGDMAPT
SCHEMBL30540735 0.84 TRPA1 (0.50) ALDH1A1TSHRFDPSTTRHPGD
SCHEMBL1620788 0.84 ALDH1A1 (0.54) ALDH1A1TSHRFDPSHPGDTDP1
SCHEMBL28589373 0.83 ALDH1A1 (0.72) ALDH1A1TSHRFDPSTTRAOX1
SCHEMBL9677313 0.83 ALDH1A1 (0.72) ALDH1A1TSHRFDPSTTRAOX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025119216-A1 BORONIC ACID β-LACTAMASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF 珠海联邦制药股份有限公司 2025-06-12 WO disclosed
US-20240238445-A1 INHIBITORS AND USES THEREOF NEURACLE SCIENCE CO., LTD. (KR) 2024-07-18 US disclosed
EP-4367090-A1 INHIBITORS AND USES THEREOF Neuracle Science Co., Ltd. (KR) 2024-05-15 EP disclosed
CN-117279887-A Inhibitors and uses thereof 纽洛可科学有限公司 2023-12-22 CN disclosed
US-20230137943-A1 PHOTOPROXIMITY PROFILING OF PROTEIN-PROTEIN INTERACTIONS IN CELLS THE UNIVERSITY OF CHICAGO 2023-05-04 US disclosed
WO-2023281476-A1 INHIBITORS AND USES THEREOF NEURACLE SCIENCE CO., LTD. (KR) 2023-01-12 WO disclosed
US-20220289657-A1 COMPOSITION FOR PREVENTING OR TREATING BACTERIAL INFECTIOUS DISEASE COMPRISING 4-GINGEROL DERIVATIVE COMPOUND AS ACTIVE INGREDIENT KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION, SEJONG CAMPUS (KR) 2022-09-15 US disclosed
US-11166891-B2 Bis phenyl hexa trien derivatives, preparation method thereof, and composition for skin whitening containing the same as an active ingredient KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2021-11-09 US disclosed
US-11166891-B2 Bis phenyl hexa trien derivatives, preparation method thereof, and composition for skin whitening containing the same as an active ingredient KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2021-11-09 US disclosed
WO-2021040333-A1 COMPOSITION FOR PREVENTING OR TREATING BACTERIAL INFECTIOUS DISEASE COMPRISING 4-GINGEROL DERIVATIVE COMPOUND AS ACTIVE INGREDIENT 고려대학교 세종산학협력단 2021-03-04 WO disclosed
EP-2194046-A1 Triazolone derivative Eisai R&D Management Co., Ltd. (JP) 2010-06-09 EP disclosed
US-20100130738-A1 PYRAZOLONE DERIVATIVE AND PDE INHIBITOR CONTAINING THE SAME AS ACTIVE INGREDIENT KYORIN PHARMACEUTICAL CO., LTD. (JP) 2010-05-27 US disclosed
US-20100130738-A1 PYRAZOLONE DERIVATIVE AND PDE INHIBITOR CONTAINING THE SAME AS ACTIVE INGREDIENT KYORIN PHARMACEUTICAL CO., LTD. (JP) 2010-05-27 US disclosed
EP-2168959-A1 PYRIDAZINONE DERIVATIVE AND PDE INHIBITOR CONTAINING THE SAME AS ACTIVE INGREDIENT Kyorin Pharmaceutical Co., Ltd. (JP) 2010-03-31 EP disclosed
EP-2168960-A1 PYRAZOLONE DERIVATIVE AND PDE INHIBITOR CONTAINING THE SAME AS ACTIVE INGREDIENT Kyorin Pharmaceutical Co., Ltd. (JP) 2010-03-31 EP disclosed
US-20100048887-A1 COMPOUNDS INCLUDING AN ANTI-INFLAMMATORY PHARMACORE AND METHODS OF USE REATA PHARMACEUTICALS, INC. 2010-02-25 US disclosed
EP-2149548-A1 METHOD FOR THE CHEMICAL SYNTHESIS OF CAPSINOIDS Universidad De Cádiz (ES) 2010-02-03 EP disclosed
EP-2000465-A1 TRIAZOLONE DERIVATIVE Eisai R&D Management Co., Ltd. (JP) 2008-12-10 EP disclosed
US-20080015199-A1 Triazolone derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-01-17 US disclosed
US-5861532-A Solid-phase synthesis of N-alkyl amides CHIRON CORPORATION (US) 1999-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11166891-B2 Bis phenyl hexa trien derivatives, preparation method thereof, and composition for skin whitening containing the same as an active ingredient TYR, MITF, TPH1 ALDH1A1 1592/4885TSHR 2021/4885FDPS 4132/4885
US-20100130738-A1 PYRAZOLONE DERIVATIVE AND PDE INHIBITOR CONTAINING THE SAME AS ACTIVE INGREDIENT PDE3A, PDE3B, PDE2A ALDH1A1 121/4885TSHR 2842/4885FDPS 1463/4885
US-20220289657-A1 COMPOSITION FOR PREVENTING OR TREATING BACTERIAL INFECTIOUS DISEASE COMPRISING 4-GINGEROL DERIVATIVE COMPOUND AS ACTIVE INGREDIENT HSD11B1, GRHPR, TIPRL ALDH1A1 3013/4885TSHR 2594/4885FDPS 290/4885
US-20100048887-A1 COMPOUNDS INCLUDING AN ANTI-INFLAMMATORY PHARMACORE AND METHODS OF USE PTGES, PTGS1, PTGES2 ALDH1A1 609/4885TSHR 3315/4885FDPS 1124/4885
US-20230137943-A1 PHOTOPROXIMITY PROFILING OF PROTEIN-PROTEIN INTERACTIONS IN CELLS PPIA, S100A4, S100A6 ALDH1A1 2889/4885TSHR 4066/4885FDPS 2079/4885
US-20240238445-A1 INHIBITORS AND USES THEREOF FAM20C, LRRC59, PDLIM5 ALDH1A1 4550/4885TSHR 4191/4885FDPS 3222/4885
US-20080015199-A1 Triazolone derivatives F3, F12, F2 ALDH1A1 710/4885TSHR 104/4885FDPS 4229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.